# BOVA - Veterinary Pharmaceuticals; Veterinary Specials

> Bova is a veterinary specials manufacturer providing high-quality veterinary pharmaceuticals and special formulations to vets.

## Core Content

- [The Cyprus experience: FCoV-23 and what happened next](https://bova.vet/2026/08/12/the-cyprus-experience-fcov-23-and-what-happened-next/): A brief reminder of the FCoV-23 outbreak in 2023 in Cyprus The methodology of epidemiological monitoring of the FCoV23 in Cyprus The genetics behind the outbreakNew clinical information regarding FCoV-23 How is the situation now across the island? First prospective data regarding FCoV-23 FIP treatment response First prospective data regarding the epidemiological data in the shelters and monitoring of the FIP in Cyprus
- [Pathogenesis of FIP: understanding the basics](https://bova.vet/2026/08/11/pathogenesis-of-fip-understanding-the-basics/): Understand the basic structure of the feline coronavirus (FCoV) genome and the important differences between serotype 1 and serotype 2 FCoV. Understand the basic pathological processes underpinning FCoV infection and feline infectious peritonitis (FIP) Appreciate how the features of the FCoV genome, replication, and pathogenesis impact on diagnostics.
- [The FIP story so far: how did we go from 100% fatal to 90% cure?](https://bova.vet/2026/08/11/the-fip-story-so-far-how-did-we-go-from-100-fatal-to-90-cure/): The FIP story so far: how did we go from 100% fatal to 90% cure? Register here Already registered Overview
- [Diagnosing FIP in the era of treatment: which tests are most important?](https://bova.vet/2026/08/12/diagnosing-fip-in-the-era-of-treatment-which-tests-are-most-important/): This webinar will discuss the interpretation and limitations of commonly requested tests, including albumin-to-globulin ratio, acute-phase proteins, Rivalta testing, feline coronavirus serology, RT-qPCR and coronavirus mutation analysis. We will also consider when a negative result does not exclude FIP, and when a carefully monitored treatment trial is reasonable. By the end of the session, delegates should be able to select diagnostic tests based on the individual cat’s presentation, interpret results within the context of disease probability and make timely, evidence-based decisions about initiating antiviral treatment.
- [FIP diagnostics: PCR, ICC, IHC and the evolving role of test performance in the era of machine learning](https://bova.vet/2026/08/12/fip-diagnostics-pcr-icc-ihc-and-the-evolving-role-of-test-performance-in-the-era-of-machine-learning/): Determine when FCoV PCR, ICC, and IHC should be considered based on clinical presentation and sample accessibility Interpret the sensitivity and specificity of PCR, ICC, and IHC in the literature, and explain how these are influenced by sample type and disease presentation Select appropriate sample types for each diagnostic modality and recognise key practical limitations, including effects of sample handling, transport, and storage Evaluate how the availability of effective treatment has shifted diagnostic priorities, particularly the balance between maximising specificity versus avoiding false negatives and diagnostic delay Recognise the emerging role of data-driven approaches (including machine learning) in FIP diagnostics, and their potential to influence future interpretation and clinical decision-making

## Key Topics

- [Webinars](https://bova.vet/category/bova-webinar/)
- [Feline Infectious Peritonitis](https://bova.vet/tag/feline-infectious-peritonitis/)
- [Uncategorized](https://bova.vet/category/uncategorized/)
- [FIP survivors](https://bova.vet/tag/fip-survivors/)
- [News](https://bova.vet/category/news/)


# Last updated: 2026-08-19T02:02:37+00:00